Pharma Archives - Page 4 of 5

Speaker Interview with Momchilo Vuyisich for MarketsandMarkets Gen-Next Probiotics and Microbiome Congress

December 12, 2019December 12, 2019 MarketsandMarkets Conferences

San Diego, December 12, 2019 – MarketsandMarkets recently interviewed Momchilo Vuyisich, Founder and Chief Science Officer, Viome, Inc regarding the MarketsandMarkets Gen-Next Probiotics and Microbiome Congress taking place on February 6-7, 2020 at Sheraton San Diego Hotel & Marina, San Diego. Q. What is the real role of probiotics strains, prebiotics and symbiotic in influencing a health? What are the essentials being missed out on? A. The field has focused on taxonomy and not functions of probiotics. We need to focus on probiotic colonization and expression of beneficial functions using…

Speaker Interview with Maya Ivanjesku for MarketsandMarkets Gen-Next Probiotics and Microbiome Congress

December 12, 2019December 12, 2019 MarketsandMarkets Conferences

San Diego, December 12, 2019 – MarketsandMarkets recently interviewed Maya Ivanjesku, Chief Scientific Officer, Dakota Biotech regarding the MarketsandMarkets Gen-Next Probiotics and Microbiome Congress taking place on February 6-7, 2020 at Sheraton San Diego Hotel & Marina, San Diego. Q. What is the real role of probiotics strains., prebiotics and symbiotic in influencing a health? What are the essentials being missed out on? A. Probiotics are the guardians of our health prebiotics is a necessary nutrient that will assure the viability of flora. Having good bacteria work together is necessary…

5th Annual Infection control, Sterilization and Decontamination congress announced with Speaker Line-up of Leading NHS Hospitals.

November 18, 2019November 18, 2019 MarketsandMarkets Conferences

MarketsandMarkets is organizing its 5th Annual Infection Control, Sterilization & Decontamination in Healthcare congress at Millennium Gloucester Hotel London Kensington on 19-20March 2020, which will focus on challenges associated with HAIs. With attendance of professionals from NHS hospitals, Research Institutes and Universities specializing in Infection Control, Decontamination and Sterilization, this two-day event will present case studies on implementation of infection prevention method and various technologies in hospitals. London, November 1 – MarketsandMarkets presents to you the 5th Annual Infection Control, Sterilization & Decontamination in Healthcare Congress to be held on…

Blood infections may be caused by bacteria in probiotics in ICU patients

November 14, 2019 MarketsandMarkets Conferences

It’s gotten normal for patients in the ICU to get probiotics, both children and adult. According to the study published in Nature Medicine, between 2009 and 2014, 1.1 % of patients suffered from bacteremia who received probiotics in the hospital’s ICU. The study also stated, the microorganisms living in probiotic formulations like yogurt can cause blood infections in few cases as indicated by a study which cautions the use of the product in the hospital’s ICU. 6 ICU cases of bacteremia was compared by the researchers with another 16 patients…

Speaker Interview with Elodie Baumfeld Andre 2nd Annual MarketsandMarkets Real-World Data and Life Science Analytics Congress

September 10, 2019 MarketsandMarkets Conferences

Boston, September 9, 2019 – MarketsandMarkets recently interviewed Elodie Baumfeld Andre, Senior Director, Epidemiology Strategy Lead, Worldwide Medical & Safety, Pfizer regarding 2nd Annual MarketsandMarkets Real-World Data and Life Science Analytics Congress taking place on October 24 – 25, 2019 at DoubleTree by Hilton Boston-Downtown . Elodie Baumfeld Andre is the Epidemiology Strategy Lead within the Worldwide Medical & Safety group at Pfizer. In this role, Elodie’s focus is on generating Real World Evidence (RWE) to support regulatory decision-making and driving continued innovation by implementing novel clinical designs and developing operating models. She is…

Speaker Interview with Dr. Susan Astley for MarketsandMarkets Biomarker and Companion Diagnostics Conference

September 9, 2019September 9, 2019 MarketsandMarkets Conferences

London, September 3, 2019 – MarketsandMarkets recently interviewed Dr. Susan Astley, Division of Informatics, Imaging & Data Sciences, University of Manchester regarding MarketsandMarkets Biomarker and Companion Diagnostics Conference taking place on 3rd – 4th October 2019 at Radisson Blu Edwardian, Grafton, London, UK Q. What are the recent advances in Biomarker research/commercialization and current challenges that need immediate attention? A. The era of personalised medicine is with us. Biomarkers are crucial to identify those at risk of particular diseases, and those who would benefit from different preventative or therapeutic interventions….

Speaker Inerview with William Williams for 2nd Annual MarketsandMarkets Next Gen Immuno-Oncology Congress

August 26, 2019August 26, 2019 MarketsandMarkets Conferences

Philadelphia, USA August 10, 2019 – MarketsandMarkets recently interviewed William Williams, President, CEO BriaCell Corporation regarding the 2nd Annual MarketsandMarkets Next Gen Immuno-Oncology Congress, taking place on September 19 – 20, 2019 at Hilton Garden Inn Philadelphia Center City. Q. What are the recent advances in the immune-oncology and current challenges that need immediate attention? A. The major advance has been to crack the code of immunosuppression induced by cancer, especially via checkpoint inhibitors such as antibodies to CTLA4 and PD-1/PD-L1. This has made many tumors amenable to immunotherapy. However, the generalized nature of…

Speaker Inerview with Emmanuel Normant for 2nd Annual MarketsandMarkets Next Gen Immuno-Oncology Congress

August 9, 2019August 9, 2019 MarketsandMarkets Conferences

Philadelphia, USA August 09, 2019 – MarketsandMarkets recently interviewed Emmanuel Normant, Vice President, Preclinical Sciences, TG Therapeutics regarding the 2nd Annual MarketsandMarkets Next Gen Immuno-Oncology Congress, taking place on September 19 – 20, 2019 at Hilton Garden Inn Philadelphia Center City. Emmanuel Normant is vice president of preclinical sciences at TG Therapeutics, a clinical-stage biotech company focused on hematologic cancers and located in New-York. There, he leads the three early pipeline programs, including a novel irreversible BTK inhibitor, and anti-PD-L1 monoclonal antibody and a bispecific antibody directed against CD19 and CD47. All three assets have entered…

Speaker Interview With Frank Borriello For 2nd Annual MarketsandMarkets Next Gen Immuno-Oncology Congress

July 31, 2019 MarketsandMarkets Conferences

Philadelphia, USA July 31, 2019 – MarketsandMarkets recently interviewed Frank Borriello, CEO, Alloplex Biotherapeutics, regarding the 2nd Annual MarketsandMarkets Next Gen Immuno-Oncology Congress, taking place on September 19 – 20, 2019 at Hilton Garden Inn Philadelphia Center City. Q. What are the recent advances in the immune-oncology and current challenges that need immediate attention? A. While there have been many advances in the field of cellular therapy in oncology, the common element limiting their adoption will be reproducibility of manufacturing, whether autologous or allogeneic, as well as generalizability across multiple tumor types, whether…

Speaker Interview With Alfred Budillon FOR 4th Annual MarketsandMarkets Epigenetics Congress

July 30, 2019August 6, 2019 MarketsandMarkets Conferences

London, UK July 30, 2019 – MarketsandMarkets recently interviewed Alfred Budillon, Chief Experimental Pharmacology Unit Department, Istituto Nazionale Tumori, Italy regarding the 4th Annual MarketsandMarkets Epigenetics Congress, taking place on 3-4 October 2019 at Radisson Blu Edwardian, Grafton, London, UK. Dr. Budillon graduated in Medicine and passed the Specialty Certification in Oncology at University Federico II, Naples, Italy. He obtained the PhD in Oncology from University G. D’Annunzio of Chieti, Italy, and a master’s degree in health economy, Management and Bioethics. Dr. Budillon is currently the chief of Experimental Pharmacology, National Cancer Institute…